Cargando…

Clinical Profile and Treatment Outcomes of Amblyopia Across Age Groups

PURPOSE: The purpose is to study the clinical profile of amblyopia by age at diagnosis. SUBJECTS AND METHODS: A retrospective chart review of 327 amblyopic patients over 7 years (September 2009–December 2016) was performed, divided by age at diagnosis into four groups: <3, 3–7, 8–15, and >15 y...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Haddad, Christiane, Ismail, Karine, Jurdi, Kheir Wajiha, Keaik, Mona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6737791/
https://www.ncbi.nlm.nih.gov/pubmed/31543663
http://dx.doi.org/10.4103/meajo.MEAJO_182_17
_version_ 1783450723813425152
author Al-Haddad, Christiane
Ismail, Karine
Jurdi, Kheir Wajiha
Keaik, Mona
author_facet Al-Haddad, Christiane
Ismail, Karine
Jurdi, Kheir Wajiha
Keaik, Mona
author_sort Al-Haddad, Christiane
collection PubMed
description PURPOSE: The purpose is to study the clinical profile of amblyopia by age at diagnosis. SUBJECTS AND METHODS: A retrospective chart review of 327 amblyopic patients over 7 years (September 2009–December 2016) was performed, divided by age at diagnosis into four groups: <3, 3–7, 8–15, and >15 years. Demographics, eye conditions and eye examination parameters including visual acuity (VA), refractive errors, and motility measurements were collected. RESULTS: Mean age at diagnosis and follow-up time was 6.2 ± 6.1 years standard deviation (SD) and 12.4 months ± 20.6 SD, respectively. The most common overall cause of amblyopia was strabismus (37%) followed by anisometropia (36%). The main causes by age at diagnosis were: strabismus at <3 years, anisometropia at 3–7 years, anisometropia at 8–15 years, and mixed at >15 years. Significant improvement in VA with treatment was noted with age between 3 and 15 years (3–7 years, P = 0.001 and 8–15 years, P = 0.03). CONCLUSIONS: Strabismus was the main cause of amblyopia at <3 years of age; anisometropia was more prevalent in older children (3–15 years). The fact that more than a quarter of our amblyopic patients were detected late (after the age of 8 years) underscores the need for expanded vision screening measures in young children.
format Online
Article
Text
id pubmed-6737791
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-67377912019-09-20 Clinical Profile and Treatment Outcomes of Amblyopia Across Age Groups Al-Haddad, Christiane Ismail, Karine Jurdi, Kheir Wajiha Keaik, Mona Middle East Afr J Ophthalmol Original Article PURPOSE: The purpose is to study the clinical profile of amblyopia by age at diagnosis. SUBJECTS AND METHODS: A retrospective chart review of 327 amblyopic patients over 7 years (September 2009–December 2016) was performed, divided by age at diagnosis into four groups: <3, 3–7, 8–15, and >15 years. Demographics, eye conditions and eye examination parameters including visual acuity (VA), refractive errors, and motility measurements were collected. RESULTS: Mean age at diagnosis and follow-up time was 6.2 ± 6.1 years standard deviation (SD) and 12.4 months ± 20.6 SD, respectively. The most common overall cause of amblyopia was strabismus (37%) followed by anisometropia (36%). The main causes by age at diagnosis were: strabismus at <3 years, anisometropia at 3–7 years, anisometropia at 8–15 years, and mixed at >15 years. Significant improvement in VA with treatment was noted with age between 3 and 15 years (3–7 years, P = 0.001 and 8–15 years, P = 0.03). CONCLUSIONS: Strabismus was the main cause of amblyopia at <3 years of age; anisometropia was more prevalent in older children (3–15 years). The fact that more than a quarter of our amblyopic patients were detected late (after the age of 8 years) underscores the need for expanded vision screening measures in young children. Wolters Kluwer - Medknow 2019-08-26 /pmc/articles/PMC6737791/ /pubmed/31543663 http://dx.doi.org/10.4103/meajo.MEAJO_182_17 Text en Copyright: © 2019 Middle East African Journal of Ophthalmology http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Al-Haddad, Christiane
Ismail, Karine
Jurdi, Kheir Wajiha
Keaik, Mona
Clinical Profile and Treatment Outcomes of Amblyopia Across Age Groups
title Clinical Profile and Treatment Outcomes of Amblyopia Across Age Groups
title_full Clinical Profile and Treatment Outcomes of Amblyopia Across Age Groups
title_fullStr Clinical Profile and Treatment Outcomes of Amblyopia Across Age Groups
title_full_unstemmed Clinical Profile and Treatment Outcomes of Amblyopia Across Age Groups
title_short Clinical Profile and Treatment Outcomes of Amblyopia Across Age Groups
title_sort clinical profile and treatment outcomes of amblyopia across age groups
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6737791/
https://www.ncbi.nlm.nih.gov/pubmed/31543663
http://dx.doi.org/10.4103/meajo.MEAJO_182_17
work_keys_str_mv AT alhaddadchristiane clinicalprofileandtreatmentoutcomesofamblyopiaacrossagegroups
AT ismailkarine clinicalprofileandtreatmentoutcomesofamblyopiaacrossagegroups
AT jurdikheirwajiha clinicalprofileandtreatmentoutcomesofamblyopiaacrossagegroups
AT keaikmona clinicalprofileandtreatmentoutcomesofamblyopiaacrossagegroups